Evidence map›Paper›PMID 40841722›Full record

ArticleNature communications2025

Integrating artificial intelligence and optogenetics for Parkinson's disease diagnosis and therapeutics in male mice.

Bobae Hyeon, Jaehyun Shin, Jae-Hun Lee, Woori Kim, Jea Kwon, Heeyoung Lee, Dae-Gun Kim, Choong Yeon Kim, Sian Choi, Jae-Woong Jeong and 4 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Bobae HyeonDepartment of Life Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.ORCID http://orcid.org/0009-0004-1006-4777
Jaehyun Shin *Innovation, AKQA, Victoria, VIC, Australia.ORCID http://orcid.org/0000-0002-1056-7102
Jae-Hun Lee *Center for Cognition and Sociality, Institute for Basic Science (IBS), Daejeon, Republic of Korea.ORCID http://orcid.org/0000-0003-2317-9958
Woori KimMolecular Neurobiology Laboratory, McLean Hospital and Department of Psychiatry, Harvard Medical School, Belmont, MA, USA.
Jea KwonMax Planck Institute for Security and Privacy (MPI-SP), Bochum, Germany.ORCID http://orcid.org/0000-0003-4318-4383
Heeyoung LeeDepartment of Life Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
Dae-Gun KimDepartment of Brain and Cognitive Sciences, KAIST, Daejeon, Republic of Korea.
Choong Yeon KimSchool of Electrical Engineering, KAIST, Daejeon, Republic of Korea.ORCID http://orcid.org/0000-0002-0674-7215
Sian ChoiDepartment of Life Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.ORCID http://orcid.org/0009-0006-6953-6200
Jae-Woong JeongSchool of Electrical Engineering, KAIST, Daejeon, Republic of Korea.ORCID http://orcid.org/0000-0001-7607-5453
Kwang-Soo KimMolecular Neurobiology Laboratory, McLean Hospital and Department of Psychiatry, Harvard Medical School, Belmont, MA, USA.ORCID http://orcid.org/0000-0002-6081-9857
C Justin LeeCenter for Cognition and Sociality, Institute for Basic Science (IBS), Daejeon, Republic of Korea. cjl@ibs.re.kr.ORCID http://orcid.org/0000-0002-3555-0980
Daesoo KimDepartment of Brain and Cognitive Sciences, KAIST, Daejeon, Republic of Korea. daesoo@kaist.ac.kr.ORCID http://orcid.org/0000-0001-9915-1463
Won Do HeoDepartment of Life Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea. wondo@kaist.ac.kr.ORCID http://orcid.org/0000-0001-7541-7319

Funding

Korea Health Industry Development Institute (KHIDI) RS-2024-00440398
6 · The paper itself

Abstract

Parkinson's disease (PD), a progressive neurodegenerative disorder, presents complex motor symptoms and lacks effective disease-modifying treatments. Here we show that integrating artificial intelligence (AI) with optogenetic intervention, termed optoRET, modulating c-RET (REarranged during Transfection) signalling, enables task-independent behavioural assessments and therapeutic benefits in freely moving male AAV-hA53T mice. Utilising a 3D pose estimation technique, we developed tree-based AI models that detect PD severity cohorts earlier and with higher accuracy than conventional methods. Employing an explainable AI technique, we identified a comprehensive array of PD behavioural markers, encompassing gait and spectro-temporal features. Moreover, our AI-driven analysis highlights that optoRET effectively alleviates PD progression by improving limb coordination and locomotion and reducing chest tremor. Our study demonstrates the synergy of integrating AI and optogenetic techniques to provide an efficient diagnostic method with extensive behavioural evaluations and sets the stage for an innovative treatment strategy for PD.

Indexed as

Artificial IntelligenceOptogeneticsParkinson DiseaseAnimalsBehavior, AnimalDisease Models, AnimalGaitHumansMaleMiceMice, Inbred C57BLMice, Transgenic

Identifiers

PMID40841722
PMCPMC12370958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.